Literature DB >> 23640790

Evaluating myometrial and cervical invasion in women with endometrial cancer: comparing subjective assessment with objective measurement techniques.

F Mascilini1, A C Testa, C Van Holsbeke, L Ameye, D Timmerman, E Epstein.   

Abstract

OBJECTIVE: To compare the diagnostic accuracy of subjective ultrasound assessment with that of objective measurement techniques in the evaluation of myometrial and cervical invasion in women with endometrial cancer.
METHODS: This was a prospective multicenter study including 144 women with endometrial cancer undergoing transvaginal ultrasound. Myometrial and cervical invasion was evaluated subjectively, as well as objectively measured in different ways: endometrial thickness, tumor/uterine anteroposterior (AP) diameter ratio, minimal tumor-free margin, minimal tumor-free margin/uterine AP diameter ratio, tumor volume (three-dimensional (3D)), tumor/uterine volume (3D) ratio, and distance from outer cervical os to lower margin of tumor (Dist-OCO). Histological assessment following hysterectomy was the gold standard.
RESULTS: The sensitivity (72%) and specificity (76%) of tumor/uterine AP diameter (at cut-off, 0.53) were not significantly different from those of subjective evaluation (sensitivity, 77% (P = 0.44); specificity, 81% (P = 0.32)) for the prediction of deep myometrial invasion; all other objective measurement techniques had either a significantly lower sensitivity or a lower specificity. For all objective measurement techniques, except minimal tumor-free margin/uterine AP diameter ratio, fixing the sensitivity at the same level as that of subjective evaluation (i.e. 77%) gave a significantly lower specificity. Dist-OCO was the only parameter that might have potential to predict cervical invasion; it had a non-significantly higher sensitivity than did subjective evaluation (73% vs 54%, P = 0.06), but a significantly lower specificity (63% vs 93%, P < 0.001).
CONCLUSION: Subjective assessment of cervical and myometrial invasion is as good as or better than any objective measurement technique. The tumor/uterine AP diameter ratio and minimal tumor-free margin/uterine AP diameter ratio seem to be the best objective measurement techniques to predict deep myometrial invasion. It remains to be shown if objective measurements are useful to predict cervical invasion.
Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cervical invasion; endometrial cancer; measurement; myometrial invasion; ultrasound

Mesh:

Year:  2013        PMID: 23640790     DOI: 10.1002/uog.12499

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  10 in total

1.  Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T.

Authors:  Gigin Lin; Yu-Ting Huang; Angel Chao; Yu-Chun Lin; Lan-Yan Yang; Ren-Chin Wu; Hsin-Ying Lu; Shu-Hang Ng; Koon-Kwan Ng; Chyong-Huey Lai
Journal:  Eur Radiol       Date:  2016-09-09       Impact factor: 5.315

Review 2.  Endometrial Cancer Management in Young Women.

Authors:  Anna Markowska; Anita Chudecka-Głaz; Kazimierz Pityński; Włodzimierz Baranowski; Janina Markowska; Włodzimierz Sawicki
Journal:  Cancers (Basel)       Date:  2022-04-11       Impact factor: 6.575

Review 3.  Should Endometrial Cancer Treatment Be Centralized?

Authors:  Vincenzo Dario Mandato; Andrea Palicelli; Federica Torricelli; Valentina Mastrofilippo; Chiara Leone; Vittoria Dicarlo; Alessandro Tafuni; Giacomo Santandrea; Gianluca Annunziata; Matteo Generali; Debora Pirillo; Gino Ciarlini; Lorenzo Aguzzoli
Journal:  Biology (Basel)       Date:  2022-05-18

4.  Transvaginal/transrectal ultrasound for assessing myometrial invasion in endometrial cancer: a comparison of six different approaches.

Authors:  Juan Luis Alcazar; Laura Pineda; Txanton Martinez-Astorquiza Corral; Rodrigo Orozco; Jesús Utrilla-Layna; Leire Juez; Matías Jurado
Journal:  J Gynecol Oncol       Date:  2015-07       Impact factor: 4.401

5.  The Diagnostic Accuracy of Ultrasound in Assessment of Myometrial Invasion in Endometrial Cancer: Subjective Assessment versus Objective Techniques.

Authors:  Filip Frühauf; Michal Zikan; Ivana Semeradova; Pavel Dundr; Kristyna Nemejcova; Ladislav Dusek; David Cibula; Daniela Fischerova
Journal:  Biomed Res Int       Date:  2017-07-24       Impact factor: 3.411

Review 6.  Endometrial cancer: an overview of novelties in treatment and related imaging keypoints for local staging.

Authors:  Stefania Rizzo; Marco Femia; Valentina Buscarino; Dorella Franchi; Annalisa Garbi; Vanna Zanagnolo; Maria Del Grande; Lucia Manganaro; Sarah Alessi; Caterina Giannitto; Francesca Ruju; Massimo Bellomi
Journal:  Cancer Imaging       Date:  2018-12-04       Impact factor: 3.909

7.  Association of Abnormal Pap Smear with Occult Cervical Stromal Invasion in Patients with Endometrial Cancer.

Authors:  Kewalin Khumthong; Apiwat Aue-Aungkul; Pilaiwan Kleebkaow; Bandit Chumworathayi; Amornrat Temtanakitpaisan; Wilasinee Nhokaew
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

8.  A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer.

Authors:  Michael Wong; Tejal Amin; Nikolaos Thanatsis; Joel Naftalin; Davor Jurkovic
Journal:  J Gynecol Oncol       Date:  2022-01-17       Impact factor: 4.401

9.  Efficacy of transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial invasion in patients with endometrioid endometrial cancer: a prospective comparative study.

Authors:  Anis Cerovac; Dzenita Ljuca; Lejla Arnautalic; Dubravko Habek; Gordana Bogdanovic; Jasminka Mustedanagic-Mujanovic; Gordana Grgic
Journal:  Radiol Oncol       Date:  2022-02-11       Impact factor: 2.991

10.  Evaluation of menopausal endometrial lesions via mathematical modeling clinical indicators and ultrasonographic parameters.

Authors:  Yamei Zhu; Lei Tang; Qiao Chen; Man Chen
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.